|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.85 TWD | 0.00% |
|
-0.79% | +14.24% |
Taiwan Advance Bio-Pharmaceutical Inc. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported revenue was TWD 128.82 million compared to TWD 167.93 million a year ago. Net loss was TWD 36.5 million compared to net income of TWD 7.84 million a year ago.
Basic loss per share from continuing operations was TWD 0.41 compared to basic earnings per share from continuing operations of TWD 0.09 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +14.24% | 52.15M | |
| +30.55% | 52.73B | |
| +36.81% | 39B | |
| -9.06% | 38.52B | |
| +25.18% | 30.38B | |
| -11.17% | 26.39B | |
| +10.28% | 26.08B | |
| +43.88% | 14.15B | |
| +33.04% | 12.6B | |
| -6.07% | 11.51B |
TAIWAN ADVANCE BIO-PHARMACEUTICAL INC. 
